Dick, Thomas
Thomas Dick
Dick, Thomas 19..-.... professeur
VIAF ID: 92016362 (Personal)
Permalink: http://viaf.org/viaf/92016362
Preferred Forms
- 200 _ | ‡a Dick ‡b Thomas ‡f 19..-.... ‡c professeur
- 100 1 _ ‡a Dick, Thomas
- 100 1 _ ‡a Dick, Thomas
-
- 100 1 _ ‡a Dick, Thomas
-
- 100 1 _ ‡a Dick, Thomas ‡d 19..-... ‡c professeur
- 100 0 _ ‡a Thomas Dick
4xx's: Alternate Name Forms (4)
Works
Title | Sources |
---|---|
Celestial scenery : or, the wonders of the planetary system displayed | |
The Christian philosopher, or, The connection of science and philosophy with religion | |
color atlas of comparative pathology of pulmonary tuberculosis | |
Cytoplasmic dynein (ddlc1) mutations cause morphogenetic defects and apoptotic cell death in Drosophila melanogaster | |
Deletion of a unique loop in the mycobacterial F-ATP synthase γ subunit sheds light on its inhibitory role in ATP hydrolysis-driven H(+) pumping | |
Detection and treatment of subclinical tuberculosis | |
Draft Genome Sequence of Mycobacterium abscessus Bamboo | |
Drosophila DPP2C1, a novel member of the protein phosphatase 2C (PP2C) family | |
Eagle Effect in Nonreplicating Persister Mycobacteria | |
An essay on the sin and the evils of covetousness : and the happy effects which would flow from a spirit of Christian beneficence : illustrated by a variety of facts selected from sacred and civil history and other documents | |
Heterogeneity of Mycobacterium tuberculosis strains in Makassar, Indonesia. | |
How Mycobacterium tuberculosis goes to sleep: the dormancy survival regulator DosR a decade later. | |
Identification of a nitroimidazo-oxazine-specific protein involved in PA-824 resistance in Mycobacterium tuberculosis | |
Identification of New MmpL3 Inhibitors by Untargeted and Targeted Mutant Screens Defines MmpL3 Domains with Differential Resistance | |
Impact of immunopathology on the antituberculous activity of pyrazinamide | |
In vitro activities of mitomycin C against growing and hypoxic dormant tubercle bacilli. | |
In vitro activity of the chelating agents nitroxoline and oxine against Mycobacterium bovis BCG. | |
Increased alanine dehydrogenase activity during dormancy in Mycobacterium smegmatis | |
Indolcarboxamide is a preclinical candidate for treating multidrug-resistant tuberculosis | |
Indolyl Azaspiroketal Mannich Bases Are Potent Antimycobacterial Agents with Selective Membrane Permeabilizing Effects and in Vivo Activity. | |
Indolylalkyltriphenylphosphonium Analogues Are Membrane-Depolarizing Mycobactericidal Agents. | |
Inducibility of the Streptomyces traRts107-Ptra expression cassette in Mycobacterium smegmatis | |
Isoniazid resistance of exponentially growing Mycobacterium smegmatis biofilm culture | |
Lipid droplet-associated proteins are involved in the biosynthesis and hydrolysis of triacylglycerol in Mycobacterium bovis bacillus Calmette-Guerin | |
Membrane-targeting AM-0016 kills mycobacterial persisters and shows low propensity for resistance development | |
Metabolic flexibility and morphological plasticity in mycobacteria | |
Mild Nutrient Starvation Triggers the Development of a Small-Cell Survival Morphotype in Mycobacteria. | |
Missense Mutations in the Unfoldase ClpC1 of the Caseinolytic Protease Complex Are Associated with Pyrazinamide Resistance in Mycobacterium tuberculosis | |
Molecular genetic characterisation of whiB3, a mycobacterial homologue of a Streptomyces sporulation factor. | |
Mycobacterial Caseinolytic Protease Gene Regulator ClgR Is a Substrate of Caseinolytic Protease | |
Mycobacterial Cell Wall Synthesis Inhibitors Cause Lethal ATP Burst | |
The Mycobacterial Membrane: A Novel Target Space for Anti-tubercular Drugs | |
Mycobacterium bovis BCG response regulator essential for hypoxic dormancy | |
The new tuberculosis drug Perchlozone® shows cross-resistance with thiacetazone | |
Nitrate respiration protects hypoxic Mycobacterium tuberculosis against acid- and reactive nitrogen species stresses | |
The NMR solution structure of Mycobacterium tuberculosis F-ATP synthase subunit ε provides new insight into energy coupling inside the rotary engine. | |
NTM drug discovery: status, gaps and the way forward. | |
On the improvement of society by the diffusion of knowledge, or, an illustration of the advantages which would result from a more general dissemination of rational and scientific information among all ranks | |
Overexpression, purification, enzymatic and microscopic characterization of recombinant mycobacterial F-ATP synthase | |
para-Aminosalicylic acid is a prodrug targeting dihydrofolate reductase in Mycobacterium tuberculosis | |
Peptide deformylase inhibitors as potent antimycobacterial agents. | |
Pharmacokinetics-pharmacodynamics analysis of bicyclic 4-nitroimidazole analogs in a murine model of tuberculosis | |
Pharmacological and Molecular Mechanisms Behind the Sterilizing Activity of Pyrazinamide | |
Phase variation in Mycobacterium tuberculosis glpK produces transiently heritable drug tolerance | |
The philosophy of a future state | |
The philosophy of religion, or, An illustration of the moral laws of the universe | |
Positioning ribosomes on leader mRNA for translational activation of the message of an inducible Staphylococcus aureus cat gene. | |
The practical astronomer : comprising illustrations of light and colours, practical descriptions of all kinds of telescopes, the use of the equatorial-transit, circular, and other astronomical instruments, a particular account of the Earl of Rosse's large telescopes, and other topics connected with astronomy | |
Proteins of Mycobacterium bovis BCG induced in the Wayne dormancy model | |
The protonmotive force is required for maintaining ATP homeostasis and viability of hypoxic, nonreplicating Mycobacterium tuberculosis | |
Pyrazinamide Resistance Is Caused by Two Distinct Mechanisms: Prevention of Coenzyme A Depletion and Loss of Virulence Factor Synthesis | |
Pyrazinoic Acid Inhibits Mycobacterial Coenzyme A Biosynthesis by Binding to Aspartate Decarboxylase PanD. | |
Re-Understanding the Mechanisms of Action of the Anti-Mycobacterial Drug Bedaquiline | |
Reactive dirty fragments: implications for tuberculosis drug discovery. | |
Recombinase-based reporter system and antisense technology to study gene expression and essentiality in hypoxic nonreplicating mycobacteria | |
Reduced drug uptake in phenotypically resistant nutrient-starved nonreplicating Mycobacterium tuberculosis | |
Rel Is Required for Morphogenesis of Resting Cells in Mycobacterium smegmatis | |
Repositioning rifamycins for Mycobacterium abscessus lung disease | |
Resistance against membrane-inserting MmpL3 inhibitor through upregulation of MmpL5 in M. tuberculosis | |
Role for malonyl coenzyme A:acyl carrier protein transacylase (MCAT) in the growth-inhibitory effect of the calmodulin antagonist trifluoperazine in Mycobacterium bovis BCG. | |
The role of a Drosophila POU homeo domain gene in the specification of neural precursor cell identity in the developing embryonic central nervous system. | |
Screening of TB Actives for Activity against Nontuberculous Mycobacteria Delivers High Hit Rates | |
Spectrum of latent tuberculosis — existing tests cannot resolve the underlying phenotypes: author's reply | |
The spectrum of latent tuberculosis: rethinking the biology and intervention strategies | |
Structure-activity relationships of antitubercular nitroimidazoles. 3. Exploration of the linker and lipophilic tail of ((s)-2-nitro-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazin-6-yl)-(4-trifluoromethoxybenzyl)amine (6-amino PA-824). | |
Substrate specificity of the deazaflavin-dependent nitroreductase from Mycobacterium tuberculosis responsible for the bioreductive activation of bicyclic nitroimidazoles | |
Target mechanism-based whole-cell screening identifies bortezomib as an inhibitor of caseinolytic protease in mycobacteria | |
Targeted protein degradation in antibacterial drug discovery? | |
TB drug susceptibility is more than MIC | |
TBAJ-876, a 3,5-Dialkoxypyridine Analogue of Bedaquiline, Is Active against Mycobacterium abscessus | |
TBAJ-876 Displays Bedaquiline-Like Mycobactericidal Potency without Retaining the Parental Drug's Uncoupler Activity | |
TBAJ-876 Retains Bedaquiline's Activity against Subunits c and ε of Mycobacterium tuberculosis F-ATP Synthase | |
Thienopyrimidinone Derivatives That Inhibit Bacterial tRNA (Guanine37-N1)-Methyltransferase (TrmD) by Restructuring the Active Site with a Tyrosine-Flipping Mechanism | |
Towards Selective Mycobacterial ClpP1P2 Inhibitors with Reduced Activity against the Human Proteasome | |
Triacylglycerol utilization is required for regrowth of in vitro hypoxic nonreplicating Mycobacterium bovis bacillus Calmette-Guerin | |
Unique structural and mechanistic properties of mycobacterial F-ATP synthases: Implications for drug design | |
The uniqueness of subunit α of mycobacterial F-ATP synthases: An evolutionary variant for niche adaptation. | |
Upregulation of stress response genes and ABC transporters in anaerobic stationary-phase Mycobacterium smegmatis. | |
Vancomycin and Clarithromycin Show Synergy against Mycobacterium abscessus In Vitro. | |
Variations of Subunit of the Mycobacterium tuberculosis F1Fo ATP Synthase and a Novel Model for Mechanism of Action of the Tuberculosis Drug TMC207 | |
Vitamin B6 biosynthesis is essential for survival and virulence of Mycobacterium tuberculosis | |
Whole cell screen of fragment library identifies gut microbiota metabolite indole propionic acid as antitubercular |